Log In
Print
BCIQ
Print
Print this Print this
 

APD421 (formerly ACA1421)

  Manage Alerts
Collapse Summary General Information
Company Acacia Pharma Ltd.
DescriptionIV formulation of an undisclosed marketed dopamine D2 and D3 receptor antagonist
Molecular Target Dopamine D2 receptor ; Dopamine D3 receptor
Mechanism of ActionDopamine D2 receptor antagonist
Latest Stage of DevelopmentPhase II
IndicationEmesis
Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today